BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35623454)

  • 1. Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
    Mortha A; Remark R; Del Valle DM; Chuang LS; Chai Z; Alves I; Azevedo C; Gaifem J; Martin J; Petralia F; Tuballes K; Barcessat V; Tai SL; Huang HH; Laface I; Jerez YA; Boschetti G; Villaverde N; Wang MD; Korie UM; Murray J; Choung RS; Sato T; Laird RM; Plevy S; Rahman A; Torres J; Porter C; Riddle MS; Kenigsberg E; Pinho SS; Cho JH; Merad M; Colombel JF; Gnjatic S
    Gastroenterology; 2022 Sep; 163(3):659-670. PubMed ID: 35623454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
    Däbritz J
    Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
    Han X; Uchida K; Jurickova I; Koch D; Willson T; Samson C; Bonkowski E; Trauernicht A; Kim MO; Tomer G; Dubinsky M; Plevy S; Kugathsan S; Trapnell BC; Denson LA
    Gastroenterology; 2009 Apr; 136(4):1261-71, e1-3. PubMed ID: 19230854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
    Gathungu G; Kim MO; Ferguson JP; Sharma Y; Zhang W; Ng SM; Bonkowski E; Ning K; Simms LA; Croft AR; Stempak JM; Walker N; Huang N; Xiao Y; Silverberg MS; Trapnell B; Cho JH; Radford-Smith GL; Denson LA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1671-80. PubMed ID: 23749272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.
    Gathungu G; Zhang Y; Tian X; Bonkowski E; Rowehl L; Krumsiek J; Nix B; Chalk C; Trapnell B; Zhu W; Newberry R; Denson L; Li E
    World J Gastroenterol; 2018 Feb; 24(5):623-630. PubMed ID: 29434451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.
    Jurickova I; Collins MH; Chalk C; Seese A; Bezold R; Lake K; von Allmen D; Frischer JS; Falcone RA; Trapnell BC; Denson LA
    Clin Exp Immunol; 2013 Jun; 172(3):455-65. PubMed ID: 23600834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies.
    Dykes DM; Towbin AJ; Bonkowski E; Chalk C; Bezold R; Lake K; Kim MO; Heubi JE; Trapnell BC; Podberesky DJ; Denson LA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2146-54. PubMed ID: 23893081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.
    Nylund CM; D'Mello S; Kim MO; Bonkowski E; Däbritz J; Foell D; Meddings J; Trapnell BC; Denson LA
    J Pediatr Gastroenterol Nutr; 2011 May; 52(5):542-8. PubMed ID: 21502824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.
    Chuang LS; Villaverde N; Hui KY; Mortha A; Rahman A; Levine AP; Haritunians T; Evelyn Ng SM; Zhang W; Hsu NY; Facey JA; Luong T; Fernandez-Hernandez H; Li D; Rivas M; Schiff ER; Gusev A; Schumm LP; Bowen BM; Sharma Y; Ning K; Remark R; Gnjatic S; Legnani P; George J; Sands BE; Stempak JM; Datta LW; Lipka S; Katz S; Cheifetz AS; Barzilai N; Pontikos N; Abraham C; Dubinsky MJ; Targan S; Taylor K; Rotter JI; Scherl EJ; Desnick RJ; Abreu MT; Zhao H; Atzmon G; Pe'er I; Kugathasan S; Hakonarson H; McCauley JL; Lencz T; Darvasi A; Plagnol V; Silverberg MS; Muise AM; Brant SR; Daly MJ; Segal AW; Duerr RH; Merad M; McGovern DP; Peter I; Cho JH
    Gastroenterology; 2016 Oct; 151(4):710-723.e2. PubMed ID: 27377463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
    Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
    Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
    Denson LA; Jurickova I; Karns R; Shaw KA; Cutler DJ; Okou D; Valencia CA; Dodd A; Mondal K; Aronow BJ; Haberman Y; Linn A; Price A; Bezold R; Lake K; Jackson K; Walters TD; Griffiths A; Baldassano RN; Noe JD; Hyams JS; Crandall WV; Kirschner BS; Heyman MB; Snapper S; Guthery SL; Dubinsky MC; Leleiko NS; Otley AR; Xavier RJ; Stevens C; Daly MJ; Zwick ME; Kugathasan S
    Inflamm Bowel Dis; 2019 Feb; 25(3):547-560. PubMed ID: 30124884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
    Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
    Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease.
    Däbritz J; Bonkowski E; Chalk C; Trapnell BC; Langhorst J; Denson LA; Foell D
    Am J Gastroenterol; 2013 Dec; 108(12):1901-10. PubMed ID: 24145675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis.
    D'Mello S; Trauernicht A; Ryan A; Bonkowski E; Willson T; Trapnell BC; Frank SJ; Kugasathan S; Denson LA
    Inflamm Bowel Dis; 2012 Feb; 18(2):236-45. PubMed ID: 21337672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.
    Uchida K; Nakata K; Suzuki T; Luisetti M; Watanabe M; Koch DE; Stevens CA; Beck DC; Denson LA; Carey BC; Keicho N; Krischer JP; Yamada Y; Trapnell BC
    Blood; 2009 Mar; 113(11):2547-56. PubMed ID: 19282464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment.
    Agnholt J; Kelsen J; Brandsborg B; Jakobsen NO; Dahlerup JF
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):649-55. PubMed ID: 15201577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease.
    Goldstein JI; Kominsky DJ; Jacobson N; Bowers B; Regalia K; Austin GL; Yousefi M; Falta MT; Fontenot AP; Gerich ME; Golden-Mason L; Colgan SP
    Gastroenterology; 2011 Jul; 141(1):208-16. PubMed ID: 21557945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease: innate immunodeficiency?
    Yamamoto-Furusho JK; Korzenik JR
    World J Gastroenterol; 2006 Nov; 12(42):6751-5. PubMed ID: 17106921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.
    Heinzelman P; Carlson SJ; Cox GN
    Protein Eng Des Sel; 2015 Oct; 28(10):461-6. PubMed ID: 25855658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
    Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.